Viewing StudyNCT06356675



Ignite Creation Date: 2024-05-06 @ 8:22 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06356675
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-10
First Post: 2024-03-25

Brief Title: A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to Immunotherapy
Sponsor: The First Affiliated Hospital Guangzhou University of Traditional Chinese Medicine
Organization: The First Affiliated Hospital Guangzhou University of Traditional Chinese Medicine

Conditions & Keywords Data

Conditions:
Name
Advanced NSCLC
Keywords:
Name View
Progress in first-line immunotherapy View